000 01561 a2200373 4500
005 20250515215519.0
264 0 _c20110318
008 201103s 0 0 eng d
022 _a1879-0887
024 7 _a10.1016/j.radonc.2010.03.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aToulany, Mahmoud
245 0 0 _aErbB2 expression through heterodimerization with erbB1 is necessary for ionizing radiation- but not EGF-induced activation of Akt survival pathway.
_h[electronic resource]
260 _bRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
_cNov 2010
300 _a338-45 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCell Line, Tumor
650 0 4 _aErbB Receptors
_xmetabolism
650 0 4 _aGene Expression Regulation, Neoplastic
_xradiation effects
650 0 4 _aGenes, erbB-1
_xphysiology
650 0 4 _aHumans
650 0 4 _aInfrared Rays
650 0 4 _aPhosphorylation
650 0 4 _aProtein Multimerization
650 0 4 _aProto-Oncogene Proteins c-akt
_xmetabolism
650 0 4 _aReceptor, ErbB-2
_xmetabolism
700 1 _aMinjgee, Minjmaa
700 1 _aKehlbach, Rainer
700 1 _aChen, Jianyong
700 1 _aBaumann, Michael
700 1 _aRodemann, H Peter
773 0 _tRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
_gvol. 97
_gno. 2
_gp. 338-45
856 4 0 _uhttps://doi.org/10.1016/j.radonc.2010.03.008
_zAvailable from publisher's website
999 _c19708389
_d19708389